[Alteration of peripheral blood lymphocyte subsets in the patients with ovarian cancer before and after chemotherapy]. 1984

J Hamai, and K Miyahara, and H Nishimura, and M Yakushiji, and T Kato, and K Matsumoto, and K Okubo, and M Yokoyama

Peripheral blood lymphocyte subsets of 8 patients with ovarian cancer were analyzed before and after chemotherapy by using monoclonal antibody (OKT series) and laser flow cytometer (Spectrum III). The following results were obtained: There was no significant difference in the distribution of OKT3+ and 11+ cells before and after chemotherapy, and between the patient and the control groups. OKT4+ cells were significantly decreased in number after chemotherapy in the patient group when the results were compared with the control (p less than 0.001) and the pretreatment (p less than 0.05) groups respectively. OKT8+ cells were more markedly increased in number after chemotherapy in the patient group (p less than 0.05) than in the control group. OKIal+ cells were more increased in number after chemotherapy in the patient group (p less than 0.01) than the control group. The OKT4+/OKT8+ ratio in the patient group was significantly decreased after chemotherapy when the value was compared with the control (p less than 0.001) and the pretreatment (p less than 0.05) groups.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002288 Adenocarcinoma, Mucinous An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed) Carcinoma, Colloid,Carcinoma, Mucinous,Adenocarcinomas, Mucinous,Carcinomas, Colloid,Carcinomas, Mucinous,Colloid Carcinoma,Colloid Carcinomas,Mucinous Adenocarcinoma,Mucinous Adenocarcinomas,Mucinous Carcinoma,Mucinous Carcinomas
D003536 Cystadenocarcinoma A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed) Cystadenocarcinomas
D005260 Female Females
D006377 T-Lymphocytes, Helper-Inducer Subpopulation of CD4+ lymphocytes that cooperate with other lymphocytes (either T or B) to initiate a variety of immune functions. For example, helper-inducer T-cells cooperate with B-cells to produce antibodies to thymus-dependent antigens and with other subpopulations of T-cells to initiate a variety of cell-mediated immune functions. Helper Cell,Helper Cells,Helper T Cell,Helper-Inducer T-Lymphocytes,Inducer Cell,Inducer Cells,T-Cells, Helper-Inducer,T-Lymphocytes, Helper,T-Lymphocytes, Inducer,Helper T-Cells,Cell, Helper T,Cells, Helper T,Helper Inducer T Lymphocytes,Helper T Cells,Helper T-Cell,Helper T-Lymphocyte,Helper T-Lymphocytes,Helper-Inducer T-Cell,Helper-Inducer T-Cells,Helper-Inducer T-Lymphocyte,Inducer T-Lymphocyte,Inducer T-Lymphocytes,T Cell, Helper,T Cells, Helper,T Cells, Helper Inducer,T Lymphocytes, Helper,T Lymphocytes, Helper Inducer,T Lymphocytes, Inducer,T-Cell, Helper,T-Cell, Helper-Inducer,T-Cells, Helper,T-Lymphocyte, Helper,T-Lymphocyte, Helper-Inducer,T-Lymphocyte, Inducer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

J Hamai, and K Miyahara, and H Nishimura, and M Yakushiji, and T Kato, and K Matsumoto, and K Okubo, and M Yokoyama
January 1990, Journal of cancer research and clinical oncology,
J Hamai, and K Miyahara, and H Nishimura, and M Yakushiji, and T Kato, and K Matsumoto, and K Okubo, and M Yokoyama
April 2016, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences,
J Hamai, and K Miyahara, and H Nishimura, and M Yakushiji, and T Kato, and K Matsumoto, and K Okubo, and M Yokoyama
April 1993, Acta obstetricia et gynecologica Scandinavica,
J Hamai, and K Miyahara, and H Nishimura, and M Yakushiji, and T Kato, and K Matsumoto, and K Okubo, and M Yokoyama
March 2010, Archives of dermatological research,
J Hamai, and K Miyahara, and H Nishimura, and M Yakushiji, and T Kato, and K Matsumoto, and K Okubo, and M Yokoyama
June 1995, Journal of Korean medical science,
J Hamai, and K Miyahara, and H Nishimura, and M Yakushiji, and T Kato, and K Matsumoto, and K Okubo, and M Yokoyama
September 2006, World journal of gastroenterology,
J Hamai, and K Miyahara, and H Nishimura, and M Yakushiji, and T Kato, and K Matsumoto, and K Okubo, and M Yokoyama
July 1996, The Canadian journal of cardiology,
J Hamai, and K Miyahara, and H Nishimura, and M Yakushiji, and T Kato, and K Matsumoto, and K Okubo, and M Yokoyama
June 2014, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
J Hamai, and K Miyahara, and H Nishimura, and M Yakushiji, and T Kato, and K Matsumoto, and K Okubo, and M Yokoyama
April 2013, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
J Hamai, and K Miyahara, and H Nishimura, and M Yakushiji, and T Kato, and K Matsumoto, and K Okubo, and M Yokoyama
January 2023, International archives of allergy and immunology,
Copied contents to your clipboard!